Conference abstract · 10 Apr 2025
Conference abstractPublished 18 Oct 2017
Diabetic Nephropathy
Belhoul Speciality Hospital, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
DN has now emerged as the most common single cause of ESKD in the world. Indeed, over 40% of patients entering the dialysis program do so because of DN. This is basically because of at least two reasons: that diabetes especially T2D is on the increase and secondly because diabetic patients are now living longer as opposed to earlier when these patients were denied treatments like dialysis. However, even now with the full advent of dialysis, the mortality is higher among diabetic patients compared to non-diabetics in the first and fifth year after commencement of dialysis. DN is thought to result from interplay between hemodynamic and metabolic factors. The hemodynamic changes of glomerular hyperperfusion and hyperfiltration are evident long before any measurable clinical signs of DN. The best evidence to demonstrate the importance of hyperperfusion in the genesis of DN is the development of unilateral DN: One kidney is spared the development of DN because of concurrent renal artery stenosis on the ipsilateral side preventing hyperperfusion developing. Hyperglycemia plays a central role in a cascade of damaging effects mediated by cytokines and growth factors but hyperglycemia alone is not conclusive. It does not fully explain the risk of diabetic nephropathy as evidenced by experimental studies in which kidneys were transplanted from non-diabetic donors to diabetic recipients; these kidneys developed DN irrespective of the blood sugar level. Hyperglycemia is therefore important but not enough. Since not all diabetic patients develop nephropathy, there must be some predisposing factors that put these patients at a higher risk of developing this complication. These factors include genetic susceptibility, hypertension, hyperglycemia and others which denote the important role of blood sugar and BP control in preventing the development of DN.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 31 Mar 2025
Diabetic Nephropathy: Advanced Therapies For Renoprotection
Short communication · 27 Dec 2024
Understanding diabetic nephropathy: pathophysiology, diagnosis, and treatment approaches.
Perspective · 30 Nov 2024
Innovative Approaches in the Management of Diabetic Nephropathy: A Comprehensive Review
Perspective · 28 Oct 2024
Diabetic Nephropathy: A Leading Cause of End-Stage Renal Disease
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Mustafa Nur Elhuda Suleiman”

